Dr. Enid Neptune

Dr. Neptune is a pulmonary, critical care physician with expertise in genetic disorders of the matrix with pulmonary manifestations. She is also skilled in the management of patients with advanced obstructive lung disease, especially emphysema. Dr. Neptune has extensive expertise in the diagnosis and management of the pulmonary complications of Marfan Syndrome, Loeys-Dietz Syndrome, vascular Ehlers Danlos Syndrome and other matrix disorders and serves on the Professional Advisory Board of the Marfan Foundation. She is also an expert on tobacco dependence and is the Vice-Chair of the Tobacco Action Committee of the American Thoracic Society. Dr. Neptune earned her M.D. from Harvard Medical School. She completed her residency and performed a fellowship in pulmonary and critical care at the University of California, San Francisco. She also performed a fellowship in genetics at Johns Hopkins. Her research interests include therapeutic strategies in Marfan syndrome; mechanisms and prevention of progression of COPD; and hepatocyte growth factor signaling in airspace homeostasis. Dr. Neptune is committed to creating a diverse research community and clinical workforce. She is involved in multiple diversity initiatives at Johns Hopkins and the American Thoracic Society. She is also involved in increasing awareness of tobacco dependence and the needed regulatory policies. Dr. Neptune serves on the Compliance Compensation Subcommittee for the Department of Medicine.

Dr. Neptune is rated as an Experienced provider by MediFind in the treatment of Hypersensitivity Pneumonitis. Her top areas of expertise are Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Acute Interstitial Pneumonia, Interstitial Lung Disease, and Emphysema.

Her clinical research consists of co-authoring 64 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Hypersensitivity Pneumonitis.